End stage renal disease. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: Intervention group will receive 500 mg of vitamin C intravenously three times a week after every dialysis session for 8 weeks. Intervention 2: Control group will receive 5 cc normal s
Treatment - Drugs
Placebo
Intervention group will receive 500 mg of vitamin C intravenously three times a week after every dialysis session for 8 weeks.
Control group will receive 5 cc normal saline intravenously 3 times a week after every dialysis session for 8 weeks.
Sponsors
Research Deputy of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: inclusion criteria: at least 6 months hemodialysis history; serum phosphor level higher than 5.5. exclusion criteria: history of liver failure; heart failure; respiratory failure and history of vitamin c intake.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum level of phosphor. Timepoint: Baseline and 2 months after. Method of measurement: paraclinical.;Serum calcium level. Timepoint: Baseline and 2 months after. Method of measurement: paraclinical.;Blood Hemoglobin level. Timepoint: Baseline and 2 months after. Method of measurement: paraclinical.;Serum PTH. Timepoint: Baseline and 2 months after. Method of measurement: paraclinical. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Jalal Etemadi
Tabriz University of Medical Sciences
Outcome results
None listed